Neuropathic pain. G89.29
Conditions
Interventions
Intervention 1: Pregabalin The initial dose of the drug at the beginning of the study was 75 mg tablets of Sobhan Iran Company twice a day, Sobhan Company of Iran. Intervention 2: Nortriptyline receiv
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Having an age of 65-18 years History of 5% or more burns above body level Have a pain score of 4 or higher (moderate to severe pain) based on the Brief Pain Inventory (BPI-P) Informed written consent and the ability to confirm in writing the participation in the study No history of allergy to pregabalin and nortriptyline Ability to swallow capsules Not pregnant and communicating with the research team.
Exclusion criteria
Exclusion criteria: History of consecutive use of any anticonvulsant medication during and after the burn History of pre-burn neuropathic pain A specific history of mental illness or substance abuse before and after burns
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score less than 4. Timepoint: In the recovery unit (0 hours) and 24 hours after the procedure, pain intensity is measured in two groups with pain criterion (BPI-P). Method of measurement: In this way, people are asked to show their pain intensity on a 10 cm ruler. no pain will be scored as zero and score 10 is for the highest pain. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactCyrus Emir Alavi
Rasht University of Medical Sciences
Outcome results
None listed